Class Action Lawsuit Over EpiPen Pricing, Kickbacks Allowed to Proceed
Mylan must face a class action lawsuit over claims of price-fixing and bribery after a federal judge refused to dismiss their claims.
Tag Archives: Mylan
-
-
Generic EpiPens May Malfunction, Deliver Double Dose, FDA Warns
The FDA warns that some generic EpiPens may deliver an overdose of epinephrine due to a missing component.
-
EpiPen Problems May Lead To Premature Device Activation, FDA Warns
Mylan and the FDA warn that EpiPens may go off prematurely if they experience sideways pressure, and in some cases may become stuck in their carriers.
-
Generic Axid Recall Issued Over Presence of Cancer-Causing Chemical NDMA
A generic Axid recall has been issued after the discovery of trace amounts of NDMA in the active ingredient.
-
Colon Cancer Lawsuit Filed Over Use Of Recalled Valsartan Products
A valsartan recall lawsuit claims that years of using the hypertension drugs led to a case of colon cancer.
-
Valsartan Lawsuit Filed Over Liver Cancer, Esophageal Cancer from Recalled Hypertension Drug
A valsartan lawsuit blames recalled pills contaminated with NDMA and NDEA for causing a man to develop liver and esophageal cancers.
-
Lawsuit Over Valsartan Recall Filed Against Mylan
A valsartan recall claims Mylan delayed pulling tainted drugs from pharmacy shelves in order to increase profits, putting consumers at risk.
-
EpiPen Auto-Injectors May Get Stuck In Carrier Tube, FDA Warns
Mylan and the FDA warn that some EpiPen and EpiPen Jr. Auto-Injectors may jam due to problems with the label, preventing potentially life-saving epinephrine during a severe allergic reaction.
-
Use of Epinephrine To Save Cardiac Arrest Patients May Carry Neurological Risks: Study
A new study indicates epinephrine use increased the risk of surviving cardiac arrest, but also appeared to increase the risk of neurologic damage among survivors.
-
EpiPen Failures Caused At Least Seven Deaths This Year, According to FDA Data
The FDA received more than 200 reports of EpiPen failures this year by mid-September, including seven reports of consumer deaths, according to a Freedom of Information Act request.
